Impact of comorbidities on the outcome of elderly patients with acute myeloid leukemia.

被引：0
|
作者：
Etienne, Anne
Esterni, Benjamin
Charbonnie, Aude
Prebet, Thomas
Coso, Diane
Stoppa, Anne-Marie
D'Incan, Evelyne
Sainty, Danile
Arnoulet, Christine
Mozziconacci, Marie-Joelle
Gastaut, Jean-Albert
Vey, Norbert
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, Lab Biopathol, F-13009 Marseille, France
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.1976.1976
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1976
引用
收藏
页码：559A / 559A
页数：1
相关论文
共 50 条
  • [1] Impact of CRi on the outcome of elderly patients with acute myeloid leukemia
    Etienne, Anne
    Charbonnier, Aude
    Prebet, Thomas
    Coso, Diane
    Stoppa, Anne-Marie
    D'Incan, Evelyne
    Doglio, Marie-Francoise
    Sainty, Daniele
    Mozziconacci, Marie-Joelle
    Rey, Jerome
    Gastaut, Jean-Albert
    Vey, Norbert
    BLOOD, 2007, 110 (11) : 164B - 164B
  • [2] Quality of life in elderly patients with acute myeloid leukemia.
    Oliva, Esther N.
    Latagliata, Roberto
    Vincelli, Lolanda
    Specchia, Giorgina
    Ronco, Francesca
    Liso, Vincenzo
    Impera, Stefana
    Alati, Caterina
    Quota, Alessandra
    Alimena, Giuliana
    Breccia, Massimo
    Carmosino, Ida
    Fortugno, Francesco
    Nobile, Francesco
    BLOOD, 2006, 108 (11) : 947A - 948A
  • [3] Tailored Temozolomide Therapy for Elderly Patients with Acute Myeloid Leukemia.
    Medeiros, Bruno C.
    Gotlib, Jason R.
    Coutre, Steven E.
    Mignea, Angela
    Zehnder, James
    BLOOD, 2008, 112 (11) : 351 - 351
  • [4] Impact of CRi on the Outcome of Elderly Patients with Untreated Acute Myeloid Leukemia (AML)
    Etienne, Anne
    Charbonnier, Aude
    Prebet, Thomas
    Coso, Diane
    D'Incan, Evelyne
    Doglio, Marie-Francoise
    Sainty, Daniele
    Mozziconacci, Marie-Joelle
    Rey, Jerome
    Vey, Norbert
    BLOOD, 2008, 112 (11) : 1027 - 1027
  • [5] Impact of Comorbidities on Prognosis of Elderly Patients with Acute Myeloid Leukemia Who Receive Hypomethylating Agents
    Marconi, Giovanni
    Candoni, Anna
    di Nicola, Roberta
    Sartor, Chiara
    Parisi, Sarah
    Abbenante, Mariachiara
    Nanni, Jacopo
    Cristiano, Gianluca
    Lazzarotto, Davide
    Giannini, Maria Benedetta
    Baldazzi, Carmen
    Fontana, Maria Chiara
    Bandini, Lorenza
    Ottaviani, Emanuela
    Testoni, Nicoletta
    Bezzi, Chiara Di Giovanni
    Abd-alatif, Rania
    Fanin, Renato
    Martinelli, Giovanni
    Paolini, Stefania
    Cavo, Michele
    Papayannidis, Cristina
    Curti, Antonio
    BLOOD, 2021, 138
  • [6] Prognostic significance of age and cytogenetics in elderly patients with acute myeloid leukemia.
    Usui, N
    Dobashi, N
    Kato, A
    Maki, N
    Asai, O
    Kobayashi, T
    Tajima, N
    Kuraishi, Y
    BLOOD, 1997, 90 (10) : 3798 - 3798
  • [7] Serum cobalamin level and clinical outcome in patients with acute myeloid leukemia.
    Bai, Li-Yuan
    Chen, Tzu-Ting
    Li, Long-Yuan
    Chiu, Chang-Fang
    CANCER RESEARCH, 2013, 73 (08)
  • [8] Prognostic significance of risk group stratification in elderly patients with acute myeloid leukemia.
    Wahlin, A
    Markevarn, B
    Golovleva, I
    Nilsson, M
    BLOOD, 2000, 96 (11) : 207B - 207B
  • [9] Treatment conditioning variables in elderly patients with acute myeloid leukemia. An institutional experience
    Gimenez Conca, Alberto D.
    Arbelbide, Jorge A.
    Schutz, Natalia
    Otero, Victoria
    Fantl, Dorotea
    Ferreyro, Bruno
    MEDICINA-BUENOS AIRES, 2016, 76 (02) : 81 - 88
  • [10] Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia.
    Ferrara, F
    Mele, G
    Califano, C
    Palmieri, S
    Pocali, B
    Denise, P
    Copia, C
    D'Arco, AM
    BLOOD, 2002, 100 (11) : 344A - 344A
12345